It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Veracyte Inc. (VCYT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.48, or 1.80%, to $27.18. The Veracyte Inc. has recorded 26,823 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Veracyte to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference.
Veracyte Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $26.70 and fluctuated between $27.27 as its day high and $26.63 as its day low. The current market capitalization of Veracyte Inc. is $1.92B. A total of 0.42 million shares were traded on the day, compared to an average of 612.71K shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, VCYT has seen 9 BUY and 10 SELL insider trades, representing the acquisition of 87,718 and the disposition of 82,630 shares. Over the last 12 months, there were 24 BUYs and 42 SELLs from insiders. Insiders purchased 509,144 shares during that period but sold 400,847.
In the most recent transaction, JONES EVAN/ FA sold 3,090 shares of VCYT for 30.17 per share on Jul 19. After the transaction, the Director now owns 35,173 company shares. In a previous transaction on Jul 19, JONES EVAN/ FA sold 838 shares at 30.14 per share. VCYT shares that Director owns now total 37,601.
Among the insiders who sold shares, BISHOP JOHN L disposed of 10,000 shares on Jul 18 at a per-share price of $30.50. This resulted in the Director holding 33,125 shares of VCYT after the transaction. In another insider transaction, JONES EVAN/ FA sold 7,441 shares at $30.19 per share on Jul 18. Company shares held by the Director now total 38,263.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for VCYT in the last 3 months, the mean price target is $33.50 with high estimates of $37.00 and low estimates of $23.00. In terms of 52-week highs and lows, VCYT has a high of $32.40 and a low of $14.92.
As of this writing, VCYT has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.17. The company reported an EPS of -$0.11 in the last quarter, which was 15.40% higher than expectations of -$0.13.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VCYT’s latest balance sheet shows that the firm has $173.20M in Cash & Short Term Investments as of fiscal 2021. There were $18.85M in debt and $64.15M in liabilities at the time. Its Book Value Per Share was $14.94, while its Total Shareholder’s Equity was $1.10B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VCYT is Buy with a score of 3.88.